Perihilar Bile Ducts

Primary Site Histology Schema Discriminator: BileDuctsDistal/BileDuctsPerihilar/CysticDuct Staging Type
C240 8000-8152, 8154-8231, 8243-8245, 8250-8576, 8940-8950, 8980-8981 010, 020, 050, 060, 999 TNM 7 and Summary Stage
C240 8153, 8232-8242, 8246-8249, 8577-8939, 8951-8979, 8982-9136, 9141-9582, 9700-9701 010, 020, 050, 060, 999 Summary Stage only

If you are working with a site/histology that only summary stages and you need to directly code it, please use the SEER Summary Stage 2000 manual

Notes

C240 Extrahepatic bile duct **Note 1:** This schema is based on the UICC chapter *Extrahepatic Bile Ducts-Perihilar,* pages 122-125. * **Site-Specific Factor 25, Schema Discriminator: BileDuctsDistal/BileDuctsPerihilar/CysticDuct** is used to discriminate between bile duct distal, bile duct perihilar and cystic duct which are coded to ICD-O-3 code C240 **Note 2:** Perihilar cholangiocarcinomas are tumors located in the extrahepatic biliary tree proximal to the origin of the cystic duct. **Note 3:** In addition to directly assigning TNM, Summary Stage 2000 (SS2000) must be captured. If directly assigning SS2000, use the *Extrahepatic Bile Duct* chapter on page 112 of the [SS2000 on-line manual](http://seer.cancer.gov/tools/ssm/SSSM2000-122012.pdf#page=112).

Main Data Items

Name Default Value Used for Staging NAACCR Item Required By Metadata
Clinical T <BLANK> Yes NAACCR #940 None
Clinical N <BLANK> Yes NAACCR #950 None
Clinical M <BLANK> Yes NAACCR #960 None
TNM Clin Stage Group 99 Yes NAACCR #970 None
Pathologic T <BLANK> Yes NAACCR #880 None
Pathologic N <BLANK> Yes NAACCR #890 None
Pathologic M <BLANK> Yes NAACCR #900 None
TNM Path Stage Group 99 Yes NAACCR #910 None
SSF10: Tumor Growth Pattern 988 No NAACCR #2864 None None
SSF11: Primary Sclerosing Cholangitis (PSC) 988 No NAACCR #2865 CCCR/Canada
COC		 None
SSF12: Carbohydrate Antigen 19-9 (CA 19-9) Lab Value 988 No NAACCR #2866 None None
SSF13: Carcinoembryonic Antigen (CEA) 988 No NAACCR #2867 None None
SSF14: Carcinoembryonic Antigen (CEA) Lab Value 988 No NAACCR #2868 None None
SSF25: Schema Discriminator: BileDuctsDistal/BileDuctsPerihilar/CysticDuct 999 Yes NAACCR #2879 All None

Additional Data Items

Name Default Value Used for Staging NAACCR Item Required By Metadata
Year of Diagnosis <BLANK> No NAACCR #390 None
Primary Site <BLANK> Yes NAACCR #400 None
Histology <BLANK> Yes NAACCR #522 None
Behavior <BLANK> Yes NAACCR #523 None
RX Summ Systemic/Surgery Sequence <BLANK> Yes NAACCR #1639 None
RX Summ Surgery/Radiation Sequence <BLANK> Yes NAACCR #1380 None
Regional Nodes Positive <BLANK> Yes NAACCR #820 None

Initial Context

Staging Methods

Expand All | Collapse All

TNM 7 Stage

Inclusion Table

Histology
8000-8152
8154-8231
8243-8245
8250-8576
8940-8950
8980-8981

Start

Additional Context
Pathologic Stage Group = 90
Clinical Stage Group = 90

Next Step

  2. Parse T
  3. clin_t_prefix
    tmp_clin_t

Next Step

  2. Parse N
  3. clin_n_prefix
    tmp_clin_n

Next Step

  2. Parse M
  3. tmp_clin_m
    clin_m_prefix

Next Step

  2. Parse T
  3. tmp_path_t
    path_t_prefix

Next Step

  2. Parse N
  3. tmp_path_n
    path_n_prefix

Next Step

  2. Parse M
  3. tmp_path_m
    path_m_prefix

Next Step

  2. Determine Default T
  3. Source T
    tmp_path_t
    tmp_clin_t
    tmp_combined_t

Next Step

  2. Determine Default N
  3. tmp_combined_n
    tmp_clin_n
    tmp_path_n
    Source N

Next Step

  2. Determine Default M
  3. tmp_path_m
    tmp_combined_m
    tmp_clin_m
    Source M

Next Step

  2. TNM 7 Stage Group
  3. Clinical Stage Group

Next Step

  2. TNM 7 Path Stage Group
  3. Pathologic Stage Group

Next Step

  2. Adjustments for No Clin or No Path
  3. tmp_combined_n
    tmp_combined_m
    Source T
    Clinical Stage Group
    Pathologic Stage Group
    Source N
    tmp_combined_t
    Source M

End

Combined Stage

Inclusion Table

Histology
8000-8152
8154-8231
8243-8245
8250-8576
8940-8950
8980-8981

Start

Additional Context
Combined Stage Group = 90
Combined N = 90
Combined M = 90
Combined T = 90

Next Step

  2. Stop if No Clin and No Path
  3. Combined M
    Combined N
    Source T
    tmp_continue
    Combined T
    Combined Stage Group
    Source N
    ss2017
    Source M

Next Step

  2. Combined T
  3. Source T
    tmp_combined_t

Next Step

  2. Combined N for Tis Cancers
  3. tmp_combined_n
    Source N

Next Step

  2. Combined M
  3. tmp_combined_m
    tmp_source_m
    Source M

Next Step

  2. Determine Combined Prefix
  3. cmb_t_prefix

Next Step

  2. Determine Combined Prefix
  3. cmb_n_prefix

Next Step

  2. Determine Combined Prefix
  3. cmb_m_prefix

Next Step

  2. Concatenate T
  3. Combined T

Next Step

  2. Concatenate N
  3. Combined N

Next Step

  2. Concatenate M
  3. Combined M

Next Step

  2. TNM 7 Path Stage Group
  3. Combined Stage Group

End

Outputs

Name Default Value Description NAACCR Item Metadata
Derived Version {{ctx_alg_version}} None None
Derived SEER Clin Stage Group 88 NAACCR #3610
None 		None
Derived SEER Path Stage Group 88 NAACCR #3605
None 		None
Derived SEER Combined Stage Group 88 NAACCR #3614
None 		None
Derived SEER Combined T 88 NAACCR #3616
None 		None
Derived SEER Combined N 88 NAACCR #3618
None 		None
Derived SEER Combined M 88 NAACCR #3620
None 		None
Derived SEER Combined T Source <BLANK> NAACCR #3622
None 		None
Derived SEER Combined N Source <BLANK> NAACCR #3624
None 		None
Derived SEER Combined M Source <BLANK> NAACCR #3626
None 		None